Tempus AI (NASDAQ:TEM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Needham & Company LLC in a research note issued to investors on Friday, Benzinga reports. They presently have a $75.00 price target on the stock. Needham & Company LLC‘s price target would suggest a potential upside of 11.74% […]

GSI Technology (NASDAQ:GSIT – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Needham & Company LLC in a research report issued on Thursday, Benzinga reports. They currently have a $9.00 target price on the semiconductor company’s stock. Needham & Company LLC‘s price target indicates a potential upside of 118.98% from […]

Needham & Company LLC reiterated their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a research report released on Monday morning,Benzinga reports. Needham & Company LLC currently has a $8.00 price objective on the stock. A number of other research firms have also recently weighed in on RXRX. Weiss Ratings reiterated […]

Needham & Company LLC restated their buy rating on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a report issued on Friday morning,Benzinga reports. They currently have a $204.00 price objective on the stock. Several other equities research analysts have also commented on NBIX. Wall Street Zen lowered shares of Neurocrine Biosciences from a […]

Needham & Company LLC reiterated their buy rating on shares of Snowflake (NYSE:SNOW – Free Report) in a report released on Monday,Benzinga reports. They currently have a $450.00 target price on the stock. Other analysts have also issued reports about the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Snowflake in a […]

Needham & Company LLC reaffirmed their buy rating on shares of Unusual Machines (NYSEAMERICAN:UMAC – Free Report) in a research report report published on Wednesday, Marketbeat.com reports. They currently have a $40.00 price target on the stock. A number of other research analysts have also weighed in on the company. Piper Sandler assumed coverage on […]